Skip to main content
Watch Insiders
PYXSHealthcare

Pyxis Oncology Inc (PYXS) Insider Trading

In the last 90 days, 4 Pyxis Oncology Inc (PYXS) insiders reported 4 open-market purchases totaling $0.00 and no sales. The most recent open-market purchase was reported on Oct 1, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
4
Latest transaction
Oct 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 1, 2026GordonMD Global Investments LPCorporate insiderOpen Market Purchase5,517,000$0.00$0.00
Oct 1, 2026GordonMD Long Biased GP LLCCorporate insiderOpen Market Purchase5,517,000$0.00$0.00
Oct 1, 2026GordonMD Long Biased Master Fund LPCorporate insiderOpen Market Purchase5,517,000$0.00$0.00
Oct 1, 2026Craig D GordonCorporate insiderOpen Market Purchase5,517,000$0.00$0.00
Jun 30, 2026Jakob DupontDirectorSale35,000$3.06$107,100

Common questions

PYXS insider trading FAQ

Are PYXS insiders buying or selling?
Over the last 90 days, PYXS insiders were net buyers, reporting $0.00 of open-market purchases and $0.00 of sales.
When was the last PYXS insider purchase?
The most recent open-market purchase of Pyxis Oncology Inc stock by an insider was reported on Oct 1, 2026, one of 4 purchases in the last 90 days.
Where does PYXS insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Pyxis Oncology Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.